chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Sever joint paint traveling through body hands wrists knees feet ankle fingers neck back. Seems to move around and worse at night. Pain medication does not work. I have been to the ER and ruled out Lime disease, Lupus. Scheduled to see Rhumitoid doctor. Doctors don?t know does not go away.
Patient was given Dtap.  She was supposed to get Tdap.   She had no adverse reactions.
Took vaccine in left arm late afternoon on Friday 2/12/21. The initial symptoms were only very painful muscle pain on the injected arm, and some mild body ache and mild chills for 2-3 days but nothing major. On Monday 2/15/21 was feeling very well and had nice workout in the morning , feeling energetic .  However, in the morning on Tuesday 2/16/21, I started having very strong abdominal cramps, feeling bloated, nausea, that was lasting for several hours and increasing in pain . After 5 hours of pain, I asked my wife to take me to Hospital. There I was diagnosed with Appendicitis after a Cat Scan. My appendix was inflamed and I had to go thru surgery that same day .
reported 30MAY96-9MAY96 had hives to face, neck back, arms facial edema so sever that eyes were swollen shut;did not affect breathing;seen by MD;hives are still present 30MAY96 severity inc & dec;MD felt caused by vax
Chills began about 3AM, then the body aches began and progressively got worse for the next 24 hours. Symptoms began to subside on 10/27/2010 10PM.  Took Tylenol every 4 hours to help with body aches and missed 1 1/2 days of work.
pt presented with redness of arm, stated it was itchy and warm; started on wednesday 7/5/23-same day of getting vaccines. pt said this was worse than from shingrix #1 in 3/23/23; recommended pt watch and wait until monday to see if redness/itchiness will resolve because for pt's first shingrix shot, redness and itchiness resolved by day 5, if not resolving or getting worse, may need to see urgent care/ pcp. recommended to put cool compress for heat and cortisone for itchiness.
Nausea beginning around 7:00 p.m. followed by chills, fever of 100 F, and vomiting on and off for several hours. Joint pain in shoulder near injection site and right hip.
This spontaneous report as received from a licensed practical nurse refers to a patient of unknown age and unknown gender. The patient pertinent medical history was not reported. On 17-JUN-2014, the patient was vaccinated with VARIVAX (Merck) (dose strength and route was not reported) (lot # J007954 and expiry date: 27-JUN-2015) which was improperly stored. Primary reporter was reporting excursion of 6 F since 01-JUN-2013 (confirmed date) affecting VARIVAX (Merck), nurse also reported that products were not stored in an overall average support range of -58 degree F and 5 degree F. No adverse effects reported. No product quality complaint (PQC) was reported for VARIVAX (Merck). This is one of the several reports from the same reporter. Additional information has been requested.
Patient had a localized reaction within an hour of getting the flu shot; her arm was hurting bad, was swollen and hot. At 3:20 pm she was taken to the school nurse to assess. She got blurry and passed out for 3-4 seconds shortly after. She was given a cold pack to put on her arm. The ambulance was called when she passed out and the EMTs did vitals and her father was on scene at that time. Patient was not transported, but went home with her dad and reported being tired. Her parents opted to have her seen on 11/08/2019. She was seen and evaluated by PA-C. An EKG was done to check for heart irregularities. Patient was improving by the time she was seen at the clinic and was fully recovered on 11/10/2019. On 11/08/2019 she developed a bruise.
20-25 ERYTHEMATOUS LESIONS WITH VESICLES IN DIFFERENT STAGES. 2-3 LESIONS NEW TODAY. ERUPTIONS BEGAN ABOUT 72 HOURS AGO.
Administration of Havrix expired dose; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a patient who received HAV (Havrix) (batch number unknown, expiry date 24th May 2022) for prophylaxis.   On 27th June 2022, the patient received Havrix. On 27th June 2022, unknown after receiving Havrix, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.   Additional Information: GSK Receipt Date: 27-Jun-2022 Reporters comment: An expired Havrix vaccines was administered to the patient. The reporter consented to follow up. Additional Supportive Information: The patient received an expired dose of Havrix, which led to expired vaccine used.
Presents on 7/16/17 with one day history of redness, swelling, pain, on right thigh where vaccine was provided. There was no redness swelling on the day the vaccine was provided. Some pain with walking. No fever. Treated today with antibiotic for secondary cellulitis.
Date of injection 10/1/13. Pt states 3 hrs after PPV23 injection (R) arm "Felt hot" and small redden area". Next day migraine headache (unrelieved by TYLENOL, but relief with EXCEDRIN Migraine) acute generalized body aches and fatigue x 2 dys.? Fever. Today (10/4) T = 97.9, site clear (injection).
Fever > 100 F Chills Tachycardia (130 bpm at rest) O2sat 93% at rest Hallucinations  Extreme fatigue X 2 days
I had a horrible case of flu-like symptoms / the worst most intense case of flu-like symptoms I've ever had; intense shivering / chills; fever but only lasted 12-14 hours; sweating; This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a 63-year-old patient who received Herpes zoster (Shingrix) for prophylaxis.   On 4th February 2020, the patient received the 1st dose of Shingrix. On an unknown date, less than 3 months after receiving Shingrix, the patient experienced influenza-like symptoms, shivering, fever and sweating. On an unknown date, the outcome of the influenza-like symptoms, shivering, fever and sweating were recovered/resolved.   It was unknown if the reporter considered the influenza-like symptoms, shivering, fever and sweating to be related to Shingrix.  Additional details were provided as follows: The patient had a horrible severe reaction- flu-like symptoms, intense shivering, chills, fever, sweating but only lasted about 12-14 hours.
bruise; Initial information received on 15-Oct-2020 regarding an unsolicited valid non-serious case received from a consumer or non-healthcare professional.  This case involves patient (unknown demographics) who experienced bruise (contusion), when received vaccine INFLUENZA VACCINE.  The patient's medical history, past medical treatment, vaccination, concomitant medication and family history were not provided.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer, lot number not reported) via an unknown route in unknown administration site prophylactic vaccination.  On an unknown date, the patient developed a bruise (contusion) (unknown latency) following the administration of INFLUENZA VACCINE.  Laboratory details were not reported.  It was not reported if the patient received a corrective treatment.  The event outcome was unknown for contusion.  There will be no information available on the batch number for this case.
Bulging fontanel 18 hours after vaccine, CBC showed WBC 20,700. Required spinal tap (normal) and overnight hospitalization for IV antibiotic.
Initial unsolicited report received from a consumer on 21 September 2016. This case involves 70 years old female patient, who was vaccinated with a dose of FLUZONE QIV (batch number, expiration date, dose, dose series were not reported) via intramuscular route, in left deltoid on 20 September 2016. The patient's illness at time of vaccination and pre-existing physician diagnosed allergies, birth defects and medical conditions were reported as none. The patient did not receive any other vaccinations within 4 weeks of vaccinations was not reported. On 20 September 2016 at 6 pm, same day after following the vaccination, patient had developed symptoms of chills, trembling, temperature of 102 degree Fahrenheit, and felt tired. Other lab data was reported as none. Corrective treatment were not reported. Patient recovered from all events on an unknown date. List of documents held by sender: none.
feel weak; this one really scared me; bone pain; Dizzy; arm is still painful; I do not know what happened in the last 2 days, I woke up some hours ago did not know where I was, what had happened; Joint pain; Achy, body pain; worst experience, I was in coma for 2 days; hallucinated; was sweating all over; Did not eat in two days; not woke up, just sleep; This spontaneous case was reported by a consumer and describes the occurrence of COMA (worst experience, I was in coma for 2 days) and HALLUCINATION (hallucinated) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 033C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Previously administered products included for an unreported indication: PNEUMOCOCCAL VACCINE and Flu vaccine. Past adverse reactions to the above products included No adverse event with Flu vaccine and PNEUMOCOCCAL VACCINE.    On 05-May-2021 at 2:00 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, the patient experienced COMA (worst experience, I was in coma for 2 days) (seriousness criterion medically significant), HALLUCINATION (hallucinated) (seriousness criterion medically significant), HYPERHIDROSIS (was sweating all over), FEEDING DISORDER (Did not eat in two days), HYPERSOMNIA (not woke up, just sleep), BONE PAIN (bone pain), DIZZINESS (Dizzy), PAIN IN EXTREMITY (arm is still painful), CONFUSIONAL STATE (I do not know what happened in the last 2 days, I woke up some hours ago did not know where I was, what had happened), ARTHRALGIA (Joint pain) and MYALGIA (Achy, body pain). On 07-May-2021, the patient experienced FEAR (this one really scared me) and ASTHENIA (feel weak). On 07-May-2021, COMA (worst experience, I was in coma for 2 days), FEEDING DISORDER (Did not eat in two days), HYPERSOMNIA (not woke up, just sleep) and CONFUSIONAL STATE (I do not know what happened in the last 2 days, I woke up some hours ago did not know where I was, what had happened) had resolved. At the time of the report, HALLUCINATION (hallucinated), HYPERHIDROSIS (was sweating all over), FEAR (this one really scared me), DIZZINESS (Dizzy) and MYALGIA (Achy, body pain) outcome was unknown and BONE PAIN (bone pain), ASTHENIA (feel weak), PAIN IN EXTREMITY (arm is still painful) and ARTHRALGIA (Joint pain) had not resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was withdrawn on an unknown date.       The patient did not receive any treatment medication. No concomitant medication was reported.   The patient spoke to his doctor about not getting the 2nd shot.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
woke up at 6 am with excruciating all over muscle and joint pain, fever, chills, headache. This very same thing happened on my second dose but much worse, I coulnt walk,
Throat started feeling odd at 1:30. Then my voice changed and throat started to close more by 4:00. Onset of fever. By 5:30 I had 10:30. It broke at 10:30pm. I took 50 mg BENADRYL at 4:10. 1 ADVIL at 5:00.
1st dose of COVID19 (Pfizer) vaccine received on 12/29/2020.  Day #1 (12/30/2020) following 1st vaccine individual developed arm soreness and redness at injection site.  On Day #5 (1/2/2021), body ache, fatigue, and headache, plus development of skin eruptions on tops (anterior) of hands and arms (bilateral).  Skin eruptions associated with significant pruritus and pain.  Individual thought reaction was related to eczema (past medical history) and treatment initiated with topical steroid and hydroxyzine without relief.  Received  2nd dose of COVID19 (Pfizer) vaccine on 1/19/2021.  Following receipt of 2nd dose, skin eruptions progressed to involvement of back (posterior/dorsal) of arms/wrist, chest, face, and scalp.  Currently 2 weeks post-2nd vaccine, individual continues to have skin eruptions present with persistent pruritus and pain.
Tired, achy, nausea, head ache, muscle pain. Pain at injection site. Symptoms lasted 2-3 days.
Eight days after injection, the injection site was painful and red. Also had higher than normal blood pressure.
This case was reported by a consumer and described the occurrence of back pain in a male patient who received SHINGRIX. On 4th May 2018, the patient received SHINGRIX. In May 2018, 3 days after receiving SHINGRIX, the patient experienced back pain, inflammation localized, pain in hip, coxarthritis, muscle pain, muscle inflammation and injection site swelling. On an unknown date, the outcome of the back pain, inflammation localized, pain in hip, coxarthritis, muscle pain and muscle inflammation were not recovered/not resolved and the outcome of the injection site swelling was recovered/resolved. It was unknown if the reporter considered the back pain, inflammation localized, pain in hip, coxarthritis, muscle pain, muscle inflammation and injection site swelling to be related to SHINGRIX. Additional details were provided as follows: The age at the vaccination was not reported. The patient experienced pain and inflammation in the back, hips and other muscles and joints. The reporter wanted to know if could expect these events to subside. The patient stated that the first symptoms appeared 3 to 4 days after the vaccination. The typical site swelling subsided after the first few days.
skin blisters; skin peels; eyes are puffy; recurring rash on the cheeks and forehead/cheeks and forehead, get red; This is a spontaneous report received from a contactable consumer (patient). A 62-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), first single dose at the end of Mar2021 and second single dose on an unspecified date, both via an unspecified route of administration (Batch/Lot number was not reported) for covid-19 immunisation. The patient medical history and concomitant medications were not reported. Caller reported that about 10 days after she got the first vaccine, she got a recurring rash on the cheeks and forehead, around the second week of April, which comes and goes, and when it comes back, her skin blisters and peels. Caller states it may not be a coincidence, and it started after the first vaccine. Caller states it has continued after the second vaccine. Caller reports that when she gets this rash, her eyes get puffy, and her cheeks and forehead, get red. Caller states the rash goes away and comes back again. Caller states she has ruled out, other causes, like soap, shampoo, makeup and food. Caller states her sister told her it looks like a Lupus butterfly rash, and she believes that she does not have Lupus. Outcome of the events was unknown.   Information about Lot/Batch number cannot be obtained. Additional information has been requested.
Dark urine; Yellow stools; This spontaneous case was reported by a consumer and describes the occurrence of FAECES DISCOLOURED (Yellow stools) and CHROMATURIA (Dark urine) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Mar-2021, the patient experienced FAECES DISCOLOURED (Yellow stools). On an unknown date, the patient experienced CHROMATURIA (Dark urine). At the time of the report, FAECES DISCOLOURED (Yellow stools) and CHROMATURIA (Dark urine) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to US-MODERNATX, INC.-MOD-2021-114672 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 08-Jun-2021: Significant follow up; Sender's Comments: Very limited information regarding these events has been provided at this time. Further information has been requested. US-MODERNATX, INC.-MOD-2021-114672:reporter's case
Booster Dose (dose 2/3/4) pfizer covid 19 vaccine and Dose 1 JANSSEN covid 19 vaccine; Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 58-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 13Sep2022 at 15:00 as dose 4 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 30Oct2021 as dose 2 (booster), single (Batch/Lot number: unknown), in left arm and on 01Apr2022 as dose 3 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation; coviD-19 vaccine nrvv ad26 (jnj 78436735) (COVID-19 VACCINE JANSSEN), on 02Apr2021 as dose 1, single (Batch/Lot number: unknown), in left arm for covid-19 immunisation. The patient's relevant medical history included: "asthma" (unspecified if ongoing); "GERD" (unspecified if ongoing); "high cholesterol" (unspecified if ongoing). Concomitant medication(s) included: SYMBICORT; FLONASE [FLUTICASONE PROPIONATE]. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant), outcome "unknown", described as "Booster Dose (dose 2/3/4) pfizer covid 19 vaccine and Dose 1 JANSSEN covid 19 vaccine"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "not recovered" and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (unspecified date) Negative; (unspecified date) Negative; (unspecified date) Positive, notes: Continued to test positive on day 3 of isolation; (28Sep2022) Positive, notes: Tested positive 8 days after finishing Paxlovid. Therapeutic measures were taken as a result of drug ineffective, covid-19 (Paxlovid from 15Sep2022 to 20Sep2022). Clinical course: Patient had no known allergies. Tested positive 8 days after finishing Paxlovid, after having tested negative twice. Started isolation again. Continued to test positive on day 3 of isolation. Sinus symptoms continued but did not worsen.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report was received from a certified medical assistant and refers to a 12 month old patient of unknown gender. The patient's pertinent medical history and concurrent conditions were not provided. On 02-NOV-2015, the patient was vaccinated with a dose of VARIVAX (Merck) lot # K005428, expiration date 15-APR-2016, 0.5 ml, intramuscular. Concomitant therapy information was not provided. On 02-NOV-2015, there was incorrect product storage and incorrect route of drug administration as the patient received improperly stored VARIVAX (Merck) via intramuscular. Also on the same date, the patient had a PPD tuberculin test placed and the results were not provided (medication error). No adverse events were reported. It was unknown if the patient sought medical attention. At the time of the report, the patient's status was unknown. This is one of several reports received from the same source. Additional information has been requested.
body aches, chills, nausea, vomiting/dry heaving, mild diarreha, fatigue
Received 1.0 ml Flu vaccine IM. Arm - more sore- lasted 4-5 days, low grade temperature for 1 day (took Tylenol) better on 5th day (felt better).
pt experienced "she was driving in the car and she suddenly has a feeling of something in the center of her chest that shot up into her eyes and she had blurred vision.  Pt stated also that was associated with a warm feeling, this lasted less than 5 minutes". No soreness or redness at injection site. Today pt reports no chest pain, shortness of breath, palpitations, or any issues with her visions since Saturday.
This report was received from a pharmacist and described an adult female (the reporter's spouse) who tested positive for hep B surface antigen after receiving hep B vaccine recombinant (Engerix B) for prophylaxis. On an unspecified date in approximately June 2003, the pt received the first dose of Engerix B. The pt also received an injection of tetanus toxoid and "one other" unidentified vaccine. Approximately three months post-immunization, in September 2003, the pt tested positive for hep b surface antigen. The reporter considered the positive test to be possibly related to Engerix B administration.
Pt devel generalized rash & itchiness, tight chest p/14 min post MMR vax; Taken to ER; Not in resp distress; No edema of lips; Good air entry-bilateral wheezing; Given DPH & Epi;
Injection site swollen, painful, red, and warm to touch. Child states it "itches".
rash, fever, chills, nausea, anorexia, diarrhea, edema, joint pain, papules; sx started on 8APR94 pt in hosp from 12APR-18APR: tx Pred dx Henoch Schonlein Purpura;
Day 1- soreness in arm Day 2- super sore and stiff Day 3- slightly sore Day 4 at 830pm- bloodshot eyes, burning sensation throughout my whole body. My feet felt like they were on fire. I felt discombobulated, cloudy and weak. I went to the ER, that will be listed in ite. 19. Day 5- super weak and still out of it but the burning sensation is gone.
Vaccine vial stored longer the  recommended time frame, potentially stored up to 28 ,  no adverse effects, no illness
9 month old baby received GARDASIL 9; patient not experiencing symptoms/ no further AE; This spontaneous report has been received from a consumer, referring to a 9-month-old male. The patient's concurrent conditions, medical history and concomitant therapies were not reported.   On an unknown date, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection, lot #T039467, expiration date: 20-MAY-2023, administered for prophylaxis (strength and route of administration were not provided) (product use issue) no additional adverse event were reported.
This case was reported by a healthcare professional and described the occurrence of injection site rash in a 40 year old male subject who was vaccinated FluLaval for prophylaxis. Medical history included non smoker and non drinker. On 17 November 2006 the subject received a dose FluLaval in an unspecified arm. On 17 November 2006, the subject also received Havrix at an unspecified site of injection. The healthcare professional noted that at the site of the FluLaval injection, on 17 November 2006, less than one day after vaccination with FluLaval, the subject experienced " a breakout of rash on the arm of the injection site with a black dot in the middle of the injection site." The events resolved on 20 November 2006. The healthcare professional considered the events to possibly be related to vaccination with FluLaval.
09/03/22 presents to EC ED for "altered mentation". PMHx of " seizures on Depakote, hypertension, bradycardia"